WHO preferred product characteristics for respiratory syncytial virus (RSV) vaccines
World Health Organization. (2017). WHO preferred product characteristics for respiratory syncytial virus (RSV) vaccines. World Health Organization. http://www.who.int/iris/handle/10665/258705. License: CC BY-NC-SA 3.0 IGO
Gov't Doc #WHO/IVB/17.11
MetadataShow full item record
Showing items related by title and MeSH subject.
WHO informal consultation on surveillance of respiratory syncytial virus on the WHO Global Influenza Surveillance and Response System (GISRS) platform, 25–27 March 2015, Geneva, Switzerland = Surveillance du virus respiratoire syncytial par le biais du système mondial OMS de surveillance de la grippe et de riposte: consultation informelle convoquée par l’OMS du 25 au 27 mars 2015 à Genève, Suisse World Health Organization = Organisation mondiale de la Santé (2016-01-08)
Circulation of Respiratory Syncytial Virus in Morocco during 2014-2016: Findings from a sentinel-based virological surveillance system for influenza Bimouhen, A.; El Falaki, F.; Ihazmad, H.; Regragui, Z.; Benkerroum, S.; Barakat, A. (2016-07)Respiratory syncytial virus [RSV] is a leading cause of mortality and morbidity in young infants, little was known on its circulation types and patterns in Morocco. We conducted a prospective study using sentinel-based influenza surveillance to detect RSV by real time PCR in patients with acute respiratory infections, enrolled during two seasons [2014/15, 2015/16]. During September 2014-April 2016, we obtained 1450 specimens, of which 267 [18.4%] tested positive for RSV. The proportion of positive RSV infection was higher in patients hospitalized ...